Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Russia bans flower imports from ArmeniaMedline launches surgical packs for animal spay/neuterTrustCo Bank declares $0.38 quarterly dividendNebius Partners with Bloom Energy for 328 MW Fuel Cell ProjectUnited Fire Group raises dividend, expands buyback programRepublic Bancorp declares $0.495 dividendTrump ballroom funding removed from spending billFed's Hawkish Drift IntensifiesFormer Habertürk editor faces up to 286 yearsProto Labs shareholders approve directors and incentive planRussia bans flower imports from ArmeniaMedline launches surgical packs for animal spay/neuterTrustCo Bank declares $0.38 quarterly dividendNebius Partners with Bloom Energy for 328 MW Fuel Cell ProjectUnited Fire Group raises dividend, expands buyback programRepublic Bancorp declares $0.495 dividendTrump ballroom funding removed from spending billFed's Hawkish Drift IntensifiesFormer Habertürk editor faces up to 286 yearsProto Labs shareholders approve directors and incentive plan
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#asco

Latest news and interesting information about asco.

Genentech to Present Breast Cancer Data at ASCO Meeting
Yesterday / 05:21
|
881

Genentech to Present Breast Cancer Data at ASCO Meeting

Genentech will present breast cancer data on giredestrant and other drugs at the 2026 ASCO meeting.

COMPANY →
0
Revolution stock buy rating from Truist
2026-05-18 11:24
|
728

Revolution stock buy rating from Truist

Truist Securities gives Revolution Medicines a buy rating with a $179 price target. Daraxon's potential and company outlook.

ANALYST RATINGS →
0
...